Alcon Labs
Recent News About Alcon Labs View More
-
Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce Initiative: Health in the 2nd Annual Anthem Awards
-
Alcon to Host 2023 Capital Markets Day
Alcon the global leader in eye care, will host its 2023 Capital Markets Day on March 30, 2023 beginning at 8:00 a.m. CT.
-
Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023
Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023
-
Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023
Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023
-
Alcon Experience Academy App Launches, Expanding Remote, On-Demand Learning Offerings
Alcon Experience Academy App Launches, Expanding Remote, On-Demand Learning Offerings
-
Alcon has over 24,000 associates
Alcon has over 24,000 associates
-
Alcon proudly recognizes Black History Month
Alcon proudly recognizes Black History Month
-
US 22, Veterans Memorial Bridge Lane, Closure to Begin on Monday, January 30, 2023
US 22, Veterans Memorial Bridge Lane, Closure to Begin on Monday, January 30, 2023
-
As the global leader in eye care,
As the global leader in eye care,
-
Alcon Champions Access to Eye Care with Opening of Children’s Vision Center in Fort Worth, Texas
Alcon Champions Access to Eye Care with Opening of Children’s Vision Center in Fort Worth, Texas
-
Regular Council Meeting on January 9
Regular Council Meeting on January 9
-
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
-
Alcon helps support research in eye health
Alcon helps support research in eye health
-
Alcon Prices US$1.3 Billion Senior Notes Offering
Alcon Inc. ("Alcon") announced that it has commenced and priced a private offering of US$700 million aggregate principal amount of its 5.375% senior notes due 2032 and US$600 million aggregate principal amount of its 5.750% senior notes due 2052 (together, the “Notes”).
-
World Sight Day 2022: Taking to the Skies to Help People Love Their Eyes
Imagine finding out that you need life-altering eye surgery to avoid permanent blindness – but the closest doctor qualified to perform the procedure is a thousand miles and an ocean away.
-
Looking Ahead: Expanding Access to Eye Care
The most obvious was the launch and adoption of innovative next-generation technology in cataract treatment, the change in patient flow (due to COVID safety concerns and protocols) and the increased interest in digital enablement of eye care professional (ECP) offices.
-
Alcon’s Phaco Development Program
At Alcon, our mission is to help every person see brilliantly. In designing world-class, digitally-enabled surgical technology and services, we aim to deliver access to care by leading innovation in all markets where we operate.
-
Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22
Alcon the global leader in eye care dedicated to helping people see brilliantly, will feature a host of innovations across its broad portfolio of products along with pertinent practice takeaways at the American Academy of Optometry Annual Meeting (#Academy22) in San Diego, California, on October 27, 2022.